IFNG and tuberculosis: Low efficacy and risk of disseminated BCG especially in immunocompromised individuals motivated to use a vaccine that can provide protective immunity response to TB by inducing Th1-type cellular immune response characterized by interferon-gamma (IFN-γ) production.